Convatec Group PLC (LON:CTEC) Stock Has Average Target Price of GBX 305.44 According to Brokerages

Shares of Convatec Group PLC (LON:CTEC) have been assigned an average rating of “Moderate Buy” from the nine analysts that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is GBX 305.44.

A number of equities analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 315 price objective on shares of Convatec Group in a report on Wednesday, August 5th. Peel Hunt reiterated an “add” rating and issued a GBX 270 price target on shares of Convatec Group in a research report on Tuesday, August 4th. Jefferies Financial Group reiterated a “buy” rating and set a GBX 300 price objective on shares of Convatec Group in a report on Wednesday, August 5th. Royal Bank Of Canada restated an “outperform” rating and set a GBX 315 target price on shares of Convatec Group in a report on Monday, August 3rd. Finally, Berenberg Bank cut their target price on shares of Convatec Group from GBX 340 to GBX 335 and set a “buy” rating for the company in a report on Friday, September 11th.

Convatec Group Trading Up 0.6%

Shares of CTEC stock opened at GBX 244.60 on Friday. The business has a 50-day moving average of GBX 225.30 and a 200 day moving average of GBX 223.11. Convatec Group has a 1-year low of GBX 193 and a 1-year high of GBX 259.30. The company has a debt-to-equity ratio of 121.83, a current ratio of 1.93 and a quick ratio of 0.96. The stock has a market capitalization of £4.69 billion, a PE ratio of 39.45, a P/E/G ratio of 0.93 and a beta of 0.77.

Insider Activity at Convatec Group

In related news, insider Tobias Hestler purchased 50,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 6th. The stock was purchased at an average cost of GBX 226 per share, with a total value of £113,000. Also, insider Jens Viebke purchased 24,400 shares of the stock in a transaction dated Tuesday, October 13th. The stock was acquired at an average price of GBX 230 per share, for a total transaction of £56,120. Corporate insiders own 0.98% of the company’s stock.

About Convatec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.